TRIM25 and central nervous system cancer: Here we demonstrate that the mRNA levels of TRIM25 are upregulated in a variety of cancer types including HCC and that upregulation of TRIM25 correlated with poor clinical outcome in patients with HCC as well as breast cancer and low grade glioma.